Masso Torrence Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$575K Buy
754
+24
+3% +$17.9K 0.24% 61
2025
Q2
$569K Buy
730
+16
+2% +$12.4K 0.26% 61
2025
Q1
$590K Buy
714
+5
+0.7% +$4.16K 0.32% 55
2024
Q4
$547K Buy
709
+6
+0.9% +$4.97K 0.29% 54
2024
Q3
$623K Buy
703
+78
+12% +$70.1K 0.34% 51
2024
Q2
$566K Buy
625
+13
+2% +$10.4K 0.31% 51
2024
Q1
$476K Buy
+612
New +$436K 0.28% 58

Other funds holding LLY

Masso Torrence Wealth Management's LLY Position: Q3 2025 in Review

Masso Torrence Wealth Management increased its Eli Lilly (LLY) stake by 3.3% in Q3 2025, buying an estimated $17.9K and bringing the position to 754 shares worth $575K. The position accounts for 0.24% of the portfolio, ranked #61.

Masso Torrence Wealth Management first reported a position in LLY in Q1 2024 and has held it in 7 quarters since. The position peaked at $623K in Q3 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Masso Torrence Wealth Management held 754 shares of Eli Lilly worth $575K as of Q3 2025.
  • Masso Torrence Wealth Management bought 24 Eli Lilly shares in Q3 2025, an estimated $17.9K.
  • Eli Lilly made up 0.24% of Masso Torrence Wealth Management's portfolio in Q3 2025, its #61 holding.
  • Masso Torrence Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 7 quarters since.
  • Masso Torrence Wealth Management's Eli Lilly position peaked at $623K in Q3 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Masso Torrence Wealth Management's 13F filing for Q3 2025, filed 20 Oct 2025.